Combined sodium-glucose-transporters inhibitors (SGLT2i) and glucagon-like-peptide receptor agonist (GLP1ra) compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
Event: ESC Congress 2024
Topic: Antidiabetic Pharmacotherapy
Session: Repurposing anti-diabetic pharmacotherapy: the new cure for all evils?
Impact of a clinician-to-clinician electronic consultation program in heart failure patients with previous hospitalization. Implications for heart failure multidisciplinary management.
Event: ESC Congress 2024
Topic: Electronic Medical Records
Session: Innovations in heart failure management: insights from clinical practice and healthcare data
Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. COMFE registry.
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: From obesity to prediction of outcomes in acute heart failure
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry
Event: ESC Congress 2024
Topic: Pharmacotherapy
Session: Cancer and other risk factors for heart disease
Combined treatment with SGLT2i and GLP1ra compared with SGLT2i or GLP1ra alone improves survival: a Real-World Registry
Event: Heart Failure 2024
Topic: Antidiabetic Pharmacotherapy
Session: Tailoring heart failure therapies on patient profiles
Impact of a clinician-to-clinician electronic consultation program in heart failure patients with previous hospital admissions. Implications for heart failure multidisciplinary management.
Event: Heart Failure 2024
Topic: Hospital Information Systems, Electronic Medical Records, Clinical Decision Support
Session: e-Cardiology/digital health
Prognostic determinants in patients with heart failure with reduced ejection fraction after a first hospitalisation for acute heart failure. implications for their clinical management. COMFE registry
Event: Heart Failure 2024
Topic: Epidemiology, Prognosis, Outcome
Session: ePosters in acute heart failure 10
Combined therapy with SGLT2i and GLP-1ra improves cardiovascular prognosis in a population with diabetes and overweigh or obesity. A real-world clinical practice study
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Diabetes and the heart (2)
A universal electronic consultation programme at the cardiology department after general practitioner referrals improves healthcare outcomes in patients with health failure
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Epidemiology, prognosis, and outcomes in acute heart failure
An electronic consultation programme impacts on heart failure patients prognosis: implications for heart failure care
Event: ESC Congress 2023
Topic: Epidemiology, Prognosis, Outcome
Session: Epidemiology, prognosis, and outcomes in acute heart failure
